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a b s t r a c t 
Objective: Interrupted time-series analyses, using 5 years of routinely collected health information system 
data, were conducted to estimate the magnitude of impact of the 2014–2015 Ebola virus disease (EVD) 
epidemic and determine trends in tuberculosis (TB) care services in Liberia. 
Methods: A segmented linear regression model was used to generate estimates and predictions for trends 
for three TB service indicators before, during, and after EVD, from January 2013 to December 2017. 
Results: It was found that the number of presumptive TB cases declined significantly at the start of 
the EVD outbreak, with an estimated loss of 3222 cases (95% confidence interval (CI) −5691 to −752; 
P = 0.014). There was also an estimated loss of 709 cases per quarter post-EVD (95% CI −1346 to −71; 
P = 0.032). However, over the post-EVD period, quarterly increases were observed in the proportion of 
smear-positive to presumptive cases (1.45%, 95% CI 0.38% to 2.5%; P = 0.011) and the proportion of treat- 
ment success to TB cases evaluated (3.3%, 95% CI 0.82% to 5.79%; P = 0.013). 
Conclusions: These findings suggest that the EVD outbreak (2014–2015) negatively affected TB care ser- 
vices. Rigorous quantitative analyses can be used to assess the magnitude of interruption and advocate 
for preparedness in settings with limited healthcare capacity. 
© 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious 
Diseases. 
This is an open access article under the CC BY-NC-ND license 



















Tuberculosis (TB) is a major public health problem in Liberia, 
here the annual incidence (including HIV + TB) is 308/100 000, 
et treatment coverage is 54% (38%–84%) ( WHO, 2018 ). Liberia is 
dentified by the World Health Organization (WHO) as a high bur- 
en country for TB and HIV-associated TB. The Ebola virus disease 
EVD) outbreak from March 2014 to May 2015 in Liberia severely ∗ Corresponding author: Keith L. Gray, Ministry of Health, Congo Town, Monrovia, 
iberia. Tel: + 231777635652. 
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icense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) mpacted the already fragile healthcare system, leading to disrup- 
ion of health services in many of the country’s 15 counties. 
During the outbreak, the establishment of Ebola treatment cen- 
ers and the consequential re-deployment of healthcare workers 
o these centers, led to understaffing of routine services. In par- 
llel, population-level intervention measures, such as curfews, bor- 
er closures, and impaired free movement, made accessing medi- 
al services or continuing drug treatments arduous ( Parpia et al., 
016 ). Drug stockouts further impaired consistent and reliable 
reatment for TB patients. TB treatment in Liberia is focused on 
acility-based drug administration, especially at the beginning of 
reatment, where direct observation is performed to maintain strict 
dherence ( Ortuno-Gutierrez et al., 2016 ). Increased transmission iety for Infectious Diseases. This is an open access article under the CC BY-NC-ND 














































































































nd decreased TB patient survival probability were attributed to 
uch factors ( Ortuno-Gutierrez et al., 2016 ). 
Several studies have examined the effects of the EVD out- 
reak on the health system in Liberia. EVD was found to nega- 
ively impact service delivery around antenatal care and delivery 
 Shannon et al., 2017 ), immunization ( Wesseh et al., 2017 ), malaria
iagnosis ( Dunbar et al., 2017 ), HIV testing and care linkage 
 Jacobs et al., 2017 ), TB case finding and treatment ( Konwloh et al.,
017 ), and primary healthcare in general ( Wagenaar et al., 2018 ). 
he majority of these studies used routinely collected data and 
id not analytically account for issues such as the similarity in 
onsecutive observations, the display of secular trends in data 
eries, and seasonal effects ( Bernal et al., 2017 ; Lagarde, 2012 ). 
oreover, some of these studies covered short post-Ebola periods 
 Konwloh et al., 2017 ), or did not consider pre-EVD trends as a
ounterfactual for evaluating EVD and post-EVD trends. One study 
 Wagenaar et al., 2018 ) with a more robust analysis of 10 primary
ealth care indicators did not examine the impact of EVD on TB 
are services and did not cover the entire country. 
Recognizing the added value of a more rigorous time-series 
nalysis, an interrupted time-series analysis was conducted to ro- 
ustly estimate the direct impact of the EVD outbreak (2014–2015) 
n TB care services in Liberia and reveal trends over a 5-year study 
eriod, using routinely collected national TB data. 
. Methods 
.1. Ethics 
Ethical approval for this study was obtained from the Pacific In- 
titute for Research and Evaluation (UL-PIRE) (Monrovia, Liberia) of 
he University of Liberia and the Ethics Board of the London School 
f Hygiene and Tropical Medicine (London, UK; reference 15637). 
s this study only used anonymous aggregate data, informed pa- 
ient consent was not required. The Ministry of Health (MOH) ad- 
itionally approved the use of the data. 
.2. Study design 
As a retrospective secondary analysis of routinely collected ag- 
regate health information system data, the study involved an in- 
errupted time-series (ITS) analysis where the ‘interruption’ was 
efined as the EVD (2014–2015) outbreak. 
.3. Study population 
All presumptive and confirmed TB cases were recorded nation- 
lly and reported centrally to the MOH, Republic of Liberia. These 
ncluded patients who were examined and treated from January 1, 
013, through December 31, 2017. As per WHO definitions, a pre- 
umptive case refers to a patient who presents with symptoms or 
igns suggestive of TB. 
.4. Data source and variables 
Data were abstracted from the headquarters of the MOH into 
 Microsoft Excel spreadsheet (Microsoft Corporate Headquarters, 
edmond, WA, USA). The data collected for TB care services con- 
ained aggregated data for the following variables on a quarterly 
asis: the quarter of the year; number of presumptive TB pa- 
ients assessed; the sputum smear result; the frequency of pa- 
ients for whom a smear was not done; the anatomical distinc- 
ion of TB stratified by age (0–4 years, 5–14 years, and ≥15 years); 
he result of complementary HIV testing, the frequency of patients 14 tarted on co-trimoxazole preventive therapy (CPT) and antiretro- 
iral therapy (ART); and the treatment outcomes (cured, com- 
lete, defaulted, failed, died) of patients with both new and re- 
apse smear-positive TB ( Konwloh et al., 2017 ). This study evalu- 
ted three outcome variables: (1) presumptive TB (proxy measure 
f functioning health centers), measuring the number of patients 
ho presented at a health facility with symptoms or signs sugges- 
ive of TB per quarter; (2) the proportion of smear-positive cases 
o presumptive cases (a measure of the case detection effort at the 
ealth facility), i.e. the percentage of smear-positive cases (inves- 
igated by smear microscopy) diagnosed out of presumptive cases 
ssessed per quarter; (3) the proportion of treatment success to TB 
ases evaluated for bacteriological evidence of cure (measure of the 
rogram’s capacity to retain patients on a full course of treatment), 
.e. the percentage of treatment success out of the total number of 
B cases evaluated per quarter. Smear-negative TB and extrapul- 
onary TB cases for which treatment was finished were classified 
s treatment completed ( Ortuno-Gutierrez et al., 2016 ). 
.5. Time 
The three outcomes were evaluated over three time periods. 
he first was the pre-EVD epidemic period, before the EVD out- 
reak, which comprised 15 months (January 1, 2013 to March 
1, 2014). As EVD was first diagnosed in Liberia on March 30, 
014 ( World Health Organization. Media Centre: WHO Statement. 
eneva: World Health Organization; 9 May 2015 ), the pre-EVD pe- 
iod included the month of March 2014. Also, TB data are aggre- 
ated quarterly. The second was the EVD epidemic period. This 
overed a period of 15 months (April 1, 2014 to June 30, 2015) 
tarting from the beginning of the first major EVD outbreak, which 
egan March 30, 2014, officially, through May 9, 2015, when Liberia 
as first declared Ebola-free. The third was the post-EVD epidemic 
eriod, covering 30 months (July 1, 2015 to December 31, 2017), 
rom the end of the first and most significant outbreak (ending 
ay 9, 2015) through December 31, 2017. Liberia subsequently ex- 
erienced 12 cases (clusters of 6, 3, 3) and was last declared Ebola- 
ree on June 9, 2016 ( WHO, 2016 ). As these subsequent cases were
ew and localized, they did not disrupt health services across the 
ountry; hence, these clusters were considered in the post-EVD pe- 
iod. 
.6. Data analysis 
The abstracted Microsoft Excel dataset was imported into Stata 
5 IC (StataCorp, College Station, TX, USA) for cleaning and analy- 
is. The dataset was set as time-series data and explored for miss- 
ng observations. One missing value for registered TB cases was 
iscovered in the dataset. As data are aggregated quarterly, at- 
empts to recover the missing value from the data source proved 
utile. For this reason, only complete quarterly records were used 
n the analyses. Descriptive analyses were done, which included 
ummary statistics of the three key indicators by periods and 
uarters, and two-way plots of TB services indicators and EVD 
ases over time. The Pearson Chi-square test for independence, or 
isher’s exact test in the case of small counts ( < 5), was run to test
or associations between period and yearly quarters. With no sig- 
ificant association between the periods and quarters per year, a 
arametric segmented linear regression model was used to gener- 
te mean estimates, control for secular trends, and adjust for po- 
ential serial correlation of the data ( Lagarde, 2012 ; Linden, 2015 ; 
agner et al., 2002 ). To adjust for autocorrelation in the data, a 
rais–Winsten estimation, autoregressive (AR) model was fitted to 
he model, for a multiple period interrupted time-series analysis 
ith the pre-EVD period used as a control group to explore coun- 
erfactual scenarios of no change during the EVD and post-EVD pe- 
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Table 1 
Time series indicating the three time periods and the three outcome variables and Ebola virus disease (EVD) cases, 2014–2016 
Yearly quarters 
Time 
( T ) 
Period 
( X ) 
Presumptive TB 
cases ( Yt ) 
Proportion of 
smear-positives/presumptive cases ( Yt ) 
Proportion of treatment 
success/ cases evaluated ( Yt ) EVD cases a 
01/01/2013 1 0 5436 16.98 74.61 
01/04/2013 2 0 6765 10.66 82.12 
01/07/2013 3 0 9876 10.52 75.25 
01/10/2013 4 0 5432 15.67 88.18 
01/01/2014 5 0 7650 9.69 74.49 8 
01/04/2014 6 1 5651 12.32 69.62 43 
01/07/2014 7 1 4307 12.98 73.27 3407 
01/10/2014 8 1 5890 7.15 66.75 4560 
01/01/2015 9 1 6989 10.40 67.02 1694 
01/04/2015 10 1 7898 10.08 64.05 954 
01/07/2015 11 2 6810 8.21 73.49 6 
01/10/2015 12 2 6780 8.51 71.06 3 
01/01/2016 13 2 9876 8.04 86.60 0 
01/04/2016 14 2 5432 12.15 88.62 3 
01/07/2016 15 2 7650 9.35 85.63 
01/10/2016 16 2 6652 11.24 84.90 
01/01/2017 17 2 5307 16.32 85.79 
01/04/2017 18 2 7890 10.08 78.42 
01/07/2017 19 2 6989 9.72 89.98 
01/10/2017 20 2 7898 11.29 86.12 
a Source: https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/case-counts.html (WHO Situation Reports). These EVD cases include all suspected, probable, and 
confirmed cases for Liberia from 2014 to 2016 aggregated quarterly. X is a dummy variable: 0, pre-EVD period; 1, EVD period; 2, post-EVD period. T is the unit time. 






































































iods ( Linden, 2015 ). The following model equation was applied: 
 t = βo + βpe T t + βe X + βe X T t + βpoe X + βpoe X T t + εt, 
here Yt is the outcome variable measured at each equally spaced 
ime point ( t ); βn represents the intercept, the starting level of the 
utcome variable; X indicates a dummy variable for the three time- 
eriods (pre-EVD, EVD, and post-EVD); Tt is the time since the 
tart of the study; βpeTt represents the pre-EVD period slope; βeX 
epresents a change in the level of outcome that begins at the start 
f the EVD period; βeXTt represents the slope of the EVD period; 
poeX represents the change in the level of the outcome at the 
tart of the post-EVD period; βpoeXT represents the slope of the 
ost-EVD period; ɛ t is a random error term for a variation. Model 
oefficients were used to generate mean estimates and trends, and 
he magnitude of impact was calculated as a difference of model 
redictions and actual quarterly data. A linear posttrend model ta- 
le was included for each outcome indicator to demonstrate trends 
fter the pre-EVD and EVD periods. Statistical significance was set 
t P < 0.05. 
. Results 
Data analyzed over the 5 years generated 20 time-points with 
 total number of 10 678 suspected, probable, and confirmed cases 
f Ebola registered from 2014 to 2016 ( Table 1 ). 
.1. Presumptive cases 
As shown in Figure 1 , the maximum number of presump- 
ive cases ( n = 9876) occurred in the pre- and post-EVD peri- 
ds, with the minimum number of presumptive cases coincid- 
ng with the peak periods of the EVD outbreak. By the regres- 
ion model, at the beginning of the pre-EVD period, the esti- 
ated number of presumptive cases was 6651, with a quarterly 
ncrease of 249 cases (95% confidence interval (CI) −382 to 881; 
 = 0.412). However, at the beginning of the EVD outbreak, there 
ppeared to be a marked decline in the number of presump- 
ive cases presenting to health centers by 3222 (95% CI −5691 
o −752; P = 0.014). This decline was followed by a gradual in- 
rease in presumptive cases by 411 per quarter (95% CI −461 to 15 236; P = 0.329) in the EVD period. At the beginning of the 
ost-EVD period, there was an increase in the number of pre- 
umptive cases, followed by a significant decreasing trend of 709 
resumptive cases (95% CI −1345 to −71; P = 0.032) per quar- 
er over the post-EVD period, when compared to the EVD pe- 
iod, as shown in Table 2a . On further evidence, separate posttrend 
stimates for the EVD period showed a significant increasing trend 
ver time of 660 presumptive cases (95% CI 24 to 1296; P = 0.042) 
er quarter in the period ( Table 2b ). Also, the post-EVD trend es- 
imates showed a declining trend in the number of presumptive 
ases per quarter when compared to the EVD period. The impact 
f EVD can be seen in Figure 2 , and the magnitude of impact
uantified during the EVD and post-EVD periods is reported in 
upplementary Material Table S1. 
.2. The proportion of smear-positive cases to presumptive cases 
The lowest proportion (7.5%) of smear-positive to presumptive 
ases occurred at the peak of the EVD outbreak, while the high- 
st proportion (16.9%) was seen at the beginning of the pre-EVD 
eriod ( Figure 3 ). The regression model estimated the proportion 
f smear-positive to presumptive cases at the beginning of the 
re-EVD period to be 14% ( Table 2a ). A decline of 0.68% was es-
imated per quarter over the pre-EVD period. At the beginning of 
he EVD period, there was an increase in the detection of smear- 
ositive cases of 1.78% (95% CI −3.61% to 7.18%; P = 0.490) per 
uarter. This was followed by a similar decreasing trend in the 
roportion of smear-positives to presumptive cases in the EVD pe- 
iod, when compared to pre-EVD trends. However, this trend was 
eversed with a significant increase in the proportion of smear- 
ositives to presumptive cases over the post-EVD period at 1.45% 
er quarter (95% CI 0.38% to 2.5%; P = 0.011) when compared 
o the EVD period. Figure 4 shows the trends in the propor- 
ion of smear-positive/presumptive cases. Evidence of this signifi- 
ance is further demonstrated in the separate post-EVD trend ta- 
le ( Table 2b ) (the difference in post-EVD coefficient of 0.30 and 
VD coefficient of −1.15 is 1.45%, as shown in the main results; 
able 2a ). Also, the impact of EVD on case detection is quantified 
n Supplementary Material Table S2. 
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Figure 1. Two-way plot of presumptive cases and Ebola virus disease (EVD) cases over time (in yearly quarters). 
EVD period, denoted with vertical red lines, begins April 1, 2014 and ends June 30, 2015. 
Table 2a 
Model regression AR(1) analysis of presumptive cases, proportion of smear-positive/presumptive cases, and proportion of treatment success/cases evaluated over the 
three time periods 
Presumptive TB cases 
Proportion of smear-positive/ presumptive 
cases 
Proportion of treatment success/ cases 
evaluated 
Time Coefficient (95% CI) P -value Coefficient (95% CI) P -value Coefficient (95% CI) P -value 
Secular trend 
( βpe T t ) 
249.14 ( −382.41, 
880.68) 
0.412 −0.68 ( −2.10, 0.73) 0.318 0.61 ( −3.03, 4.25) 0.724 
Level change ( βe X ) −3222.1 
( −5691.73, 
−752.47) 
0.014 ∗ 1.78 ( −3.61, 7.18) 0.490 −9.60 ( −25.56, 
6.36) 
0.218 
Change in trend 
( βe XT t ) 
410.96 ( −461.12, 
1283.03) 
0.329 −0.47 ( −2.04, 1.10) 0.532 −2.19 ( −6.12, 
1.74) 
0.251 
Level change ( βe X ) 94.64 ( −1818.99, 
2008.27) 
0.917 1.22 ( −2.20, 4.64) 0.458 7.79 ( −1.06, 16.65) 0.080 
Change in trend 
( βpoe XT t ) 
−708.57 
( −1345.93, −71.19) 
0.032 ∗ 1.45 (0.39, 2.52) 0.011 ∗ 3.31 (0.83, 5.80) 0.013 ∗
βn (Constant) 6651.48 (4647.55, 
8655.41) 
< 0.001 13.99 (9.98, 17.99) < 0.001 77.82 (71.30, 
84.34) 
< 0.001 
CI, confidence interval; TB, tuberculosis. ∗P -value < 0.05. 
Table 2b 
Posttrend, presumptive cases, the proportion of smear-positive/presumptive cases, and the proportion of treatment success/cases evaluated 
Presumptive TB cases Proportion of smear-positive/ presumptive cases Proportion of treatment success/ cases evaluated 
Period Coefficient (95% CI) P -value Coefficient (95% CI) P -value Coefficient (95% CI) P -value 
EVD 660.10 (24.31, 1295.87) 0.042 ∗ −1.15 ( −2.17, −0.14) 0.02 ∗ −1.58 ( −3.60, 0.44) 0.115 
Post-EVD −48.48 ( −214.62, 117.67) 0.5415 0.30 ( −0.05, 0.65) 0.09 1.73 (0.47, 3.00) 0.010 ∗


























.3. The proportion of treatment success to TB cases evaluated 
The highest proportion (90%) of treatment success to TB cases 
valuated occurred in the post-EVD period, whereas the lowest 
roportion (64%) of successful treatment occurred within the ter- 
inal stages of the EVD outbreak ( Figure 5 ). The proportion of 
reatment success to cases evaluated as estimated by the regres- 
ion model was 78% at the beginning of the pre-EVD period. The 
uarterly increase in the proportion of treatment success/TB cases 
valuated before the start of the EVD period was less than 1%. At 
he start of the EVD period, the direction of the trend reversed and 
 decreasing trend in proportion continued, with a 2.2% (95% CI 
6.1 to 1.7%; P = 0.25) decline per quarter in the EVD period. In
ontrast, the post-EVD period was notable for an increasing trend 
n the proportion of treatment success to TB cases evaluated. There 16 as a 3.3% (95% CI 0.83% to 5.79%; P = 0.013) increase in the pro-
ortion of treatment success to TB cases evaluated over the entire 
ost-EVD period. Figure 6 shows the changes in trends over the 
hree periods. Separate post-EVD predictions further demonstrated 
his increasing trend in the post-EVD period when compared to the 
VD period, with a difference in coefficients of 3.3%, as reported in 
able 2a . See Supplementary Material Table S3 for the magnitude 
f impact of EVD on the proportion of treatment success to cases 
valuated. 
. Discussion 
This study provides a robust analysis of the impact of the 
VD epidemic on three TB care service outcomes using routine 
ealth information system (RHIS) data, with an interrupted time- 
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Figure 2. Interrupted time-series graph generated from an AR(1) linear segmented regression model, adjusting for autocorrelation, showing level and slope changes across 
the Ebola virus disease (EVD) and post-EVD periods for presumptive cases. 
EVD period, denoted with vertical dashed red lines, begins April 1, 2014 and ends June 30, 2015. The pre-EVD period begins January 1, 2013 and ends March 31, 2014; the 
post-EVD period begins July 1, 2015 and ends December 31, 2017. The black lines are estimates generated from AR(1) model regression. 
Figure 3. Two-way plot of the proportion of smear-positives/presumptive cases and Ebola virus disease (EVD) cases over time (in quarters). 


































eries analysis. Previous studies have suggested that presumptive 
B cases declined in the EVD period but increased in the post- 
VD period ( Desta et al., 2019 ; Konwloh et al., 2017 ). One study
eported a significant decline in case detection in the EVD and 
ost-EVD periods ( Konwloh et al., 2017 ), and treatment success 
as significantly reduced during the EVD epidemic with improve- 
ent post-EVD. In the present study, it was found that the number 
f presumptive cases dropped significantly at the beginning of the 
VD outbreak. Whilst there was some recovery during the EVD pe- 
iod, in the post-EVD period there was a trend of further decline, 
eversing a trend to increased presumptive cases in the pre-EVD 
eriod, in contrast to previous reports ( Konwloh et al., 2017 ). It was
lso found that the proportion of smear-positives to presumptive 
ases had been in decline before the EVD outbreak and that this 
rend continued but more sharply through the EVD period. Con- 
rary to previous findings ( Konwloh et al., 2017 ), it was found that
here was a significant increase in the proportion of smear-positive 17 o presumptive cases in the post-EVD period. Finally, the model 
howed that in contrast to trends in the pre-and post-EVD periods, 
he proportion of treatment success to TB cases evaluated declined 
hroughout the EVD period. Together these results show that the 
VD epidemic likely impeded TB care services in Liberia, by reduc- 
ng the number of patients presenting for assessment, increasing 
he number of late presentations, and reducing the likelihood of 
reatment success during the EVD period. 
The number of presumptive cases declined by nearly one-fifth 
t the beginning of the EVD outbreak. This decline was consistent 
ith previous studies in Liberia ( Desta et al., 2019 ; Konwloh et al., 
017 ) and Sierra Leone ( Bah et al., 2017 ) that compared annual ag-
regates and monthly means, respectively. Rather than being iden- 
ified as presumptive TB cases, patients may instead have been 
riaged as suspected EVD cases and promptly isolated due to sim- 
larities in presentation to EVD, with symptoms such as fever and 
emoptysis. Further, the fear of contracting EVD from a health fa- 
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Figure 4. Interrupted time-series graph generated from an AR(1) linear segmented regression model, adjusting for autocorrelation, showing level and slope changes across 
the Ebola virus disease (EVD) and post-EVD periods for the proportion of smear-positives/presumptive cases. 
EVD period, denoted with vertical dashed red lines, begins April 1, 2014 and ends June 30, 2015. The pre-EVD period begins January 1, 2013 and ends March 31, 2014; the 
post-EVD period begins July 1, 2015 and ends December 31, 2017. The black lines are estimates generated from AR(1) model regression. 
Figure 5. Two-way plot of the proportion of treatment success/tuberculosis (TB) cases evaluated and Ebola virus disease (EVD) cases over time (in quarters). 




























ility and the closure of health facilities due to health worker in- 
ections, the lack of personal protective equipment (PPE), and the 
ack of isolation facilities may have prevented care-seeking. This 
ecline, however, did not persist throughout the EVD period. This 
hange may have been due to several factors. By October 2014, 
iberia’s diagnostic capacity for EVD had improved ( Raftery et al., 
018 ), thus allowing patients to access care after being screened 
or EVD. Also, by the end of 2014, the epidemic was restricted to 
everal hot spots around the country, allowing less affected areas 
o resume full essential health services. It is important to note the 
ecline in presumptive cases over the post-EVD period, reversing 
he pre-EVD trend. This highlights the potential lingering impact of 
VD on the country’s healthcare delivery system. The explanation 
or this trend is not clear; however it highlights the challenge the 18 ational TB program still faces in effectively reducing the burden 
f TB in Liberia. 
This study demonstrated a decline in the proportion of smear- 
ositive to presumptive cases from the pre-EVD period, and a sim- 
lar decline during the EVD period compared to previous studies 
 Desta et al., 2019 ; Konwloh et al., 2017 ; Ortuno-Gutierrez et al., 
016 ). A lower proportion of smear-positive to presumptive cases 
ay indicate a decline in samples submitted for testing, a decline 
n laboratory capability, or an increase in patients presenting with 
B symptoms, whether or not they really have TB. It seems more 
ikely to be one of the former explanations. A reduction in the 
umber of sputa collected for case ascertainment may be due to 
 moratorium on invasive procedures and handling of bodily flu- 
ds during the peak of the epidemic. Another reason may be a ‘no 
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Figure 6. Interrupted time-series graph generated from an AR(1) linear segmented regression model, adjusting for autocorrelation, showing level and slope changes across 
the Ebola virus disease (EVD) and post-EVD periods for the proportion of treatment success/tuberculosis (TB) cases evaluated. 
EVD period, denoted with vertical dashed red lines, begins April 1, 2014 and ends June 30, 2015. The pre-EVD period begins January 1, 2013 and ends March 31, 2014; the 











































































caution. ouch’ policy that was being carried out. This policy may have re- 
ulted in more patients being treated presumptively and recorded 
s smear-not-done pulmonary cases. However, the proportion of 
mear-positives to presumptive cases increased significantly fol- 
owing the start of the post-EVD period. This increase in proportion 
ay be the direct result of an increase in late presentations with 
mear-positive disease or due to an increase in the actual num- 
er of smear-positive cases remaining constant while presumptive 
ases declined. Facility-level data are needed to ascertain this fur- 
her. 
In alignment with previous findings ( Desta et al., 2019 ; 
onwloh et al., 2017 ), the present study found that the EVD out- 
reak adversely impacted treatment outcomes, i.e., the proportion 
f treatment success to cases evaluated. As TB cases are generally 
valuated towards the end of treatment, the impact of an interrup- 
ion in treatment was profound in the latter part of the EVD out- 
reak. This was likely the consequence of a higher loss-to-follow- 
p due to the temporary closures of health facilities in response 
o an escalating EVD epidemic. Drug stockouts and the stigmatiza- 
ion of health centers and health workers may have likewise con- 
ributed. Moreover, deaths from EVD may also have contributed to 
ttrition. Evidence has shown that EVD transmission was high in 
mpoverished communities, which is where TB in Liberia is most 
revalent ( Fallah et al., 2015 ). 
Despite the challenges for retention in care, it is notable that 
he post-EVD period saw a trend of increasing proportions of treat- 
ent success to TB cases evaluated. These improvements may 
ave been due to community mobilization to encourage treatment- 
eeking behavior, the influx of resources to bolster the health sys- 
em, and a move towards early treatment initiation in HIV-co- 
nfected patients. Overall, it is encouraging to see that the decline 
n proportions of patients achieving treatment success found dur- 
ng the EVD period was not sustained post-EVD. This may reflect 
o some extent health service recovery. Investigations into how a 
ore sustained impact of such interventions could have been at- 
ained could be instrumental in reducing the impact of an epi- 
emic response on routine health services going forward. 
The strengths of this study include the use of an interrupted 
ime-series to analyze national TB data over 5 years using na- 
ional program indicators and time trends to accurately estimate 19 he magnitude of the EVD outbreak on TB care services. This strong 
uasi-experimental design provides a robust method of measuring 
he effect of an intervention without a control group or random- 
zation ( Bernal et al., 2017 ; Lagarde, 2012 ). Using the Student t -test
o compare means for time-series data has become limited and 
ay lead to a biased result ( Box and Tiao, 1975 ; Lagarde, 2012 ).
dditionally, the study used 5 years of routine TB data that were 
ollected from both public and private facilities across the country 
nd aggregated across multiple administrative levels. Five years of 
outine data increases the accuracy of the estimation of trends over 
he three time periods and the predictions generated to estimate 
he impact of EVD on various TB care services outcomes, improving 
eneralizability. Previous studies ( Dunbar et al., 2017 ; Jacobs et al., 
017 ; Konwloh et al., 2017 ; Shannon et al., 2017 ; Wesseh et al.,
017 ) in Liberia investigating the effects of EVD on various health 
rograms using routine health data and shorter periods did not ac- 
ount for temporal trends or autocorrelation commonly found in 
outinely collected data. 
Notwithstanding, this study has several limitations. First, rou- 
inely collected data are not always reliable and lack consistent 
uality. Health system disruption may have affected data record- 
ng and collection, as limited resources were shifted towards stop- 
ing the epidemic. Also, new tools that have been in use, such 
s GeneXpert, culture, and drug susceptibility testing (DST), were 
ot reflected in the DHIS2 database, such that data did not cap- 
ure cases detected with these tools. Second, with this design, it is 
hallenging to infer direct causality because concomitant unrelated 
ctivities may be responsible directly or indirectly for changes in 
B care services ( Lagarde, 2012 ). Third, this study used an over- 
apping outcome variable (presumptive TB cases) that could have 
nfluenced the results of the proportion of smear-positive to pre- 
umptive cases. Fourth, a power calculation methodology for time- 
eries data has not been formally developed, especially for studies 
sing routine data ( Bhaskaran et al., 2013 ). Due to the retrospec- 
ive nature of the study and despite the use of all available case 
ata during the periods of interest, the study may lack the power 
o detect small changes in trends or trends over a shorter pe- 
iod, and estimates of the impact will have to be interpreted with 






















































In conclusion, this study adds quantitative insights into the 
agnitude of the impact that the EVD epidemic (2014–2015) had 
n the delivery of TB care services. A stringent estimation of the 
etrimental impact of the Liberian EVD outbreak on national TB 
ervices and the trends in the recovery period are provided, sug- 
esting an overall reduction in case detection. Even with the health 
ystem returning to normalcy, a significant decline in presump- 
ive cases and increase in the proportion of smear-positives in the 
ost-EVD period is concerning. Much still needs to be done to im- 
rove health system resilience against unprecedented pandemics, 
ike EVD and COVID-19, in order to reduce the collateral damage 
f future epidemics, particularly important for addressing the ‘long 
ail’ of impact after such health emergencies, to meet global ‘End 
B’ targets. 
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